Amarin Corporation PLC
AMRN15.390USD
+0.230+1.52%
交易中 （美東）報價延遲15分鐘
319.65M總市值
虧損本益比TTM
關於 Amarin Corporation PLC 公司
Amarin Corporation PLC 是一家制藥公司。該公司專注於改善心血管 (CV) 健康並降低 CV 風險的療法的商業化和開發。該公司通過 VASCEPA 的開發和商業化開展業務。其主要產品 Vascepa（二十碳五烯酸乙酯）膠囊可作爲飲食輔助劑，降低重度高甘油三酯血癥成年患者的甘油三酯水平。Vascepa 的這一適應症稱爲 MARINE 適應症，主要基於 MARINE 對這一獲批患者羣體進行的 Vascepa 研究結果。該公司主要向批發商以及選定的區域批發商和專業藥房供應商（統稱爲其分銷商）銷售 Vascepa，而後者又將 Vascepa 轉售給零售藥房，再轉售給患者和醫療保健提供商。
公司簡介
公司代碼AMRN
公司名稱Amarin Corporation PLC
上市日期Apr 01, 1993
CEOMr. Aaron D. Berg
員工數量275
證券類型Depository Receipt
年結日Apr 01
公司地址WeWork One Central Plaza Dame Street
城市DUBLIN
上市交易所NASDAQ Capital Market Consolidated
國家Ireland
郵編D02 K7K5
電話35316699020
網址https://amarincorp.com/
公司代碼AMRN
上市日期Apr 01, 1993
CEOMr. Aaron D. Berg
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Diane E. Sullivan
Ms. Diane E. Sullivan
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Mr. Oliver O'Connor
Mr. Oliver O'Connor
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Dr. Paul Cohen, M.D.
Dr. Paul Cohen, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Ms. Patrice Bonfiglio
Ms. Patrice Bonfiglio
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Louis Sterling, III
Mr. Louis Sterling, III
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter Fishman
Mr. Peter Fishman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Stephen B. (Steven) Ketchum, Ph.D.
Dr. Stephen B. (Steven) Ketchum, Ph.D.
President - Research and Development, Executive Vice President, Chief Scientific Officer
President - Research and Development, Executive Vice President, Chief Scientific Officer
--
--
Mr. Aaron D. Berg
Mr. Aaron D. Berg
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Keith L. Horn
Mr. Keith L. Horn
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Odysseas D. Kostas, M.D.
Dr. Odysseas D. Kostas, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Diane E. Sullivan
Ms. Diane E. Sullivan
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Mr. Oliver O'Connor
Mr. Oliver O'Connor
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Dr. Paul Cohen, M.D.
Dr. Paul Cohen, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Ms. Patrice Bonfiglio
Ms. Patrice Bonfiglio
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Louis Sterling, III
Mr. Louis Sterling, III
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter Fishman
Mr. Peter Fishman
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月23日 週三
更新時間: 7月23日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Sarissa Capital Management, L.P.
6.01%
Kynam Capital Management LP
3.00%
Acadian Asset Management LLC
0.92%
Eversept Partners, LP
0.82%
Two Sigma Investments, LP
0.79%
Other
88.47%
持股股東
持股股東
佔比
Sarissa Capital Management, L.P.
6.01%
Kynam Capital Management LP
3.00%
Acadian Asset Management LLC
0.92%
Eversept Partners, LP
0.82%
Two Sigma Investments, LP
0.79%
Other
88.47%
股東類型
持股股東
佔比
Hedge Fund
11.52%
Investment Advisor
3.36%
Investment Advisor/Hedge Fund
1.67%
Research Firm
0.96%
Individual Investor
0.95%
Pension Fund
0.14%
Family Office
0.10%
Bank and Trust
0.01%
Venture Capital
0.01%
Other
81.27%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
335
3.85M
18.62%
-1.48M
2025Q1
349
5.67M
20.22%
+144.25K
2024Q4
362
81.89M
19.91%
-21.31M
2024Q3
365
76.69M
18.66%
-50.88M
2024Q2
389
87.45M
21.29%
-59.57M
2024Q1
405
98.68M
24.03%
-57.40M
2023Q4
423
103.82M
25.42%
-56.37M
2023Q3
447
95.61M
23.44%
-78.96M
2023Q2
464
107.90M
26.46%
-89.05M
2023Q1
492
118.85M
29.19%
-104.01M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Sarissa Capital Management, L.P.
1.24M
6%
--
--
Mar 31, 2025
Kynam Capital Management LP
620.73K
3%
--
--
Mar 31, 2025
Acadian Asset Management LLC
189.58K
0.92%
+100.29K
+112.31%
Mar 31, 2025
Eversept Partners, LP
169.96K
0.82%
+94.13K
+124.13%
Mar 31, 2025
Two Sigma Investments, LP
162.85K
0.79%
-33.32K
-16.99%
Mar 31, 2025
WaterFront Wealth, Inc.
125.73K
0.61%
+1.64K
+1.32%
Mar 31, 2025
SCP Investment, LP
125.00K
0.6%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
116.05K
0.56%
-87.42K
-42.96%
Mar 31, 2025
Longitude (Cayman) Ltd
81.00K
0.39%
-37.50K
-31.65%
Dec 31, 2024
Berg (Aaron D.)
80.71K
0.39%
+36.64K
+83.12%
Jun 26, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco Nasdaq Biotechnology ETF
0.04%
SPDR S&P International Small Cap ETF
0.01%
SPDR Portfolio Developed World ex-US ETF
0%
Global X Aging Population ETF
0%
ActivePassive International Equity ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
AltShares Event-Driven ETF
0%
ProShares Ultra Nasdaq Biotechnology
佔比0.04%
Invesco Nasdaq Biotechnology ETF
佔比0.04%
SPDR S&P International Small Cap ETF
佔比0.01%
SPDR Portfolio Developed World ex-US ETF
佔比0%
Global X Aging Population ETF
佔比0%
ActivePassive International Equity ETF
佔比0%
Invesco NASDAQ Future Gen 200 ETF
佔比0%
AltShares Event-Driven ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Mar 12, 2025
Merger
20<1
公告日期
類型
比率
Mar 12, 2025
Merger
20<1
